Share this page: More
 

Secondary Faculty

Richard F. Ambinder, M.D., Ph.D., Professor
Virology and human cancer; antiviral therapy; antitumor therapy; lymphoma pathogenesis and treatment; immunological approaches to virus-associated malignancies.

James M. Berger, Ph.D., Professor
Structural and catalytic mechanisms of nucleic-acid machines and assemblies; control of DNA replication and chromosome superstructure; small-molecule and biological regulatory mechanisms.

Kristin L. Bigos, Ph.D., Assistant Professor
Using neuroimaging and genetics to develop better drugs for psychiatry.

Ted M. Dawson, M.D., Ph.D., Professor
Molecular and cellular signals controlling neurodegeneration, neuronal survival and cell death.

Samuel R. Denmeade, M.D., Professor
Targeted therapies for cancer; prodrugs; proteases; peptide libraries.

Kelly E. Dooley, M.D., Ph.D., Associate Professor
Clinical pharmacology of anti-infective agents; Evaluation of new drug regimens for the treatment of tuberculosis and co-treatment of TB and HIV.

Laura M. Ensign, Ph.D., Associate Professor
Nanomedicine for drug delivery.

Jed W. Fahey, Sc.D., Assistant Professor
Phytochemistry/nutrition-based prevention of chronic disease.

Charles W. Flexner, M.D., Professor
Basic and clinical pharmacology of antiretroviral drugs; HIV protease inhibitors and entry inhibitors.

Justin Hanes, Ph.D., Professor
Nanotechnology for Drug and Nucleic Acid Delivery.

Ling He, M.D., Ph.D., Associate Professor
Coactivators regulate metabolism and mitochondrial function.

Craig W. Hendrix, M.D., Professor
Prevention of HIV infection.

Takanari Inoue, Ph.D., Professor
Synthetic cell biology, neutrophil chemotaxis, spatio-temporal signal compartmentalization, confocal fluorescence imaging, technology development.

Matthew M. Ippolito, M.D., Assistant Professor
Chemotherapeutics for malaria control and elimination.

David A. Kass, M.D., Professor
Molecular physiology of myocardial disease.

William G. Nelson, M.D., Ph.D., Professor
DNA methylation and epigenetic gene silencing; inflammation and prostatic carcinogenesis.

Sridhar Nimmagadda, Ph.D., Associate Professor
Chemokine receptor biology and molecular imaging applications in drug development.

Brent Petty, M.D., Associate Professor
Antimicrobial chemotherapy; hospital-based medical practices; internal medicine collaboration with ophthalmologic clinical trials.

Kenneth J. Pienta, M.D., Professor
The ecology of cancer, tumor microenvironment, metastasis, biomarker development, novel therapeutic development.

Martin G. Pomper, M.D., Ph.D., Professor
Translational precision imaging.

Jonathan D. Powell, M.D., Ph.D., Professor
Mechanisms of T cell activation and tolerance.

Douglas N. Robinson, Ph.D., Professor
Understanding cytokinesis and cell shape control.

Christopher A. Ross, M.D., Ph.D., Professor
Neuropsychiatric disorders.

Theresa A. Shapiro, M.D., Ph.D., Professor
Clinical pharmacology; molecular mechanisms of antiparasitic drug action; effects of topoisomerase inhibitors on DNA of trypanosomes; structure-activity of synthetic antimalarial trioxanes.

Robert F. Siliciano, M.D., Ph.D., Professor
HIV latency, evolution, and persistence; HIV treatment and drug resistance; pharmacology of HIV drugs.

Barbara S. Slusher, Ph.D., M.A.S., Professor
Johns Hopkins Drug Discovery (JHDD)

Solomon H. Snyder, M.D., Professor
Molecular basis of neural signal transduction.

Huijun Wei, Ph.D., Assistant Professor
Identifying and validating drug targets for the treatment of neurodevelopmental disorders.

Ethel D. Weld, M.D., Ph.D., Assistant Professor
Alternative delivery strategies for HIV prevention and treatment, and expanding treatment options for special populations with TB and HIV.

Michael J. Wolfgang, Ph.D., Professor
Cellular and organismal metabolism.